Published in World J Gastroenterol on January 07, 2006
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol (2009) 1.76
A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci (2009) 1.39
Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06
Neuropathophysiology of functional gastrointestinal disorders. World J Gastroenterol (2007) 1.02
Psychiatric, somatic and other functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. J Neurogastroenterol Motil (2012) 0.99
Anti-enteric neuronal antibodies and the irritable bowel syndrome. J Neurogastroenterol Motil (2012) 0.98
Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory. Psychol Med (2013) 0.92
Interleukin-6 modulates colonic transepithelial ion transport in the stress-sensitive wistar kyoto rat. Front Pharmacol (2012) 0.87
A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome. Front Pharmacol (2012) 0.85
Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study. PLoS One (2015) 0.84
Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J Lipid Res (2009) 0.83
All Roads Lead to Rome: Update on Rome III Criteria and New Treatment Options. Gastroenterol Rep (2007) 0.82
Visceral pain and gastrointestinal microbiome. J Neurogastroenterol Motil (2015) 0.81
A novel role for the metabotropic glutamate receptor-7: modulation of faecal water content and colonic electrolyte transport in the mouse. Br J Pharmacol (2010) 0.78
Irritable Bowel Syndrome and Bronchial Asthma: Are They Associated in Indian Population? J Clin Diagn Res (2017) 0.75
Microbiota regulates visceral pain in the mouse. Elife (2017) 0.75
Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis (2017) 0.75
Psychiatric Comorbidity in Patients With Irritable Bowel Syndrome at a Tertiary Care Center in Northern India. J Neurogastroenterol Motil (2017) 0.75
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology (2005) 5.75
Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol (2000) 5.72
Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology (2002) 5.50
The role of psychological and biological factors in postinfective gut dysfunction. Gut (1999) 4.54
Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology (2001) 4.30
Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet (1996) 4.23
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology (2004) 4.05
Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology (1995) 3.95
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol (2003) 3.84
Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut (2004) 3.55
Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology (2002) 3.11
Irritable bowel syndrome--post salmonella infection. J Infect (1994) 2.68
Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology (2002) 2.52
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology (2004) 2.24
Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology. Gastroenterology (2001) 2.22
Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol (2000) 2.20
Postinfectious irritable bowel syndrome. Gastroenterology (2003) 2.12
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther (2001) 2.04
Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ (1999) 1.99
Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96
Systematic review: the influence of geography and ethnicity in irritable bowel syndrome. Aliment Pharmacol Ther (2005) 1.94
Abnormal colonic fermentation in irritable bowel syndrome. Lancet (1998) 1.91
Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64
Impaired transit and tolerance of intestinal gas in the irritable bowel syndrome. Gut (2001) 1.62
Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut (2003) 1.58
Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol (1999) 1.49
Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology (2004) 1.49
Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol (2004) 1.42
The fecal microbial population in the irritable bowel syndrome. Microbiologica (1982) 1.40
Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil (2003) 1.39
Central nervous system involvement in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol (2004) 1.29
Serotoninergic neuroenteric modulators. Lancet (2001) 1.23
Prokinetic effects in patients with intestinal gas retention. Gastroenterology (2002) 1.14
Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol (2005) 1.09
Role of nerves in enteric infection. Gut (2002) 1.06
A case for an immunological basis for irritable bowel syndrome. Gastroenterology (2002) 1.04
Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases? Chin J Dig Dis (2005) 1.01
Risk factors for colon ischemia. Am J Gastroenterol (2004) 1.00
Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea. Expert Opin Investig Drugs (2005) 0.90
Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome. Gut (2001) 0.89
Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome. J Med Microbiol (1987) 0.87
Current concepts of the irritable bowel syndrome. Scand J Gastroenterol Suppl (2003) 0.85
The use of probiotics in functional bowel disease. Gastroenterol Clin North Am (2005) 0.84
Response to intraluminal gas in irritable bowel syndrome. Motility versus perception. Dig Dis Sci (1995) 0.84
Small bowel bacterial overgrowth, celiac disease, and IBS: what are the real associations? Am J Gastroenterol (2003) 0.84
From comic relief to real understanding; how intestinal gas causes symptoms. Gut (2003) 0.82
The problem of gas in irritable bowel syndrome. Am J Gastroenterol (2000) 0.81
Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon. Gastroenterol Clin North Am (2005) 0.80
Functional gastrointestinal disease: has the genomic era arrived? Gastroenterology (2004) 0.78
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology (2005) 5.75
Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ (2008) 4.12
An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol (2009) 3.99
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol (2006) 3.24
Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol (2009) 2.73
Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry (2008) 2.52
An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut (2011) 2.49
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology (2006) 2.28
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut (2012) 2.24
Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol (2002) 2.07
Differential expression of toll-like receptors in patients with irritable bowel syndrome. Am J Gastroenterol (2010) 2.02
Systematic review on the management of chronic constipation in North America. Am J Gastroenterol (2005) 1.85
The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol (2010) 1.79
Recommendations for probiotic use--2008. J Clin Gastroenterol (2008) 1.76
An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62
Gastroenterology in developing countries: issues and advances. World J Gastroenterol (2009) 1.53
Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol (2012) 1.51
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. J Am Coll Cardiol (2009) 1.44
Passing the bug--translocation, bacteremia, and sepsis in the intensive care unit patient: is intestinal decontamination the answer? Crit Care Med (2011) 1.40
A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci (2009) 1.39
A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial. J Clin Gastroenterol (2013) 1.32
Irritable bowel syndrome: towards biomarker identification. Trends Mol Med (2009) 1.29
Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev (2011) 1.25
The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol (2009) 1.16
Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol (2013) 1.16
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis (2011) 1.14
Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol (2008) 1.11
Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci (2010) 1.11
Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol (2008) 1.10
Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol (2010) 1.10
Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain Behav Immun (2011) 1.09
The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam (2012) 1.09
Endoluminal delivery of radiofrequency energy to the gastroesophageal junction in uncomplicated GERD: efficacy and potential mechanism of action. Am J Gastroenterol (2002) 1.07
Irritable bowel syndrome: role of food in pathogenesis and management. J Dig Dis (2009) 1.06
Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes (2013) 1.01
Report from the multinational irritable bowel syndrome initiative 2012. Gastroenterology (2013) 1.01
Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. World J Gastroenterol (2006) 1.00
Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology (2006) 0.99
Aging and intestinal motility: a review of factors that affect intestinal motility in the aged. Drugs Aging (2002) 0.93
Role of radiologic imaging in irritable bowel syndrome: evidence-based review. Radiology (2011) 0.93
The overlap between IBS and IBD: what is it and what does it mean? Expert Rev Gastroenterol Hepatol (2014) 0.91
The microbiota link to irritable bowel syndrome: an emerging story. Gut Microbes (2012) 0.91
Portrait of an immunoregulatory Bifidobacterium. Gut Microbes (2012) 0.91
Recommendations for Probiotic Use-2015 Update: Proceedings and Consensus Opinion. J Clin Gastroenterol (2015) 0.89
Gastroparesis and Parkinson's disease: a systematic review. Parkinsonism Relat Disord (2011) 0.87
Gut microbiota, inflammation and symptomatic diverticular disease. New insights into an old and neglected disorder. J Gastrointestin Liver Dis (2010) 0.85
Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial. Am J Gastroenterol (2002) 0.85
Management of chronic constipation in the elderly. Drugs Aging (2008) 0.85
Small bowel bacterial overgrowth, celiac disease, and IBS: what are the real associations? Am J Gastroenterol (2003) 0.84
IBS: An epigenetic perspective. Nat Rev Gastroenterol Hepatol (2010) 0.83
Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J Lipid Res (2009) 0.83
The global perspective on irritable bowel syndrome: a Rome Foundation-World Gastroenterology Organisation symposium. Am J Gastroenterol (2012) 0.82
CT-based estimation of intracavitary gas volumes using threshold-based segmentation: in vitro study to determine the optimal threshold range. J Med Imaging Radiat Oncol (2012) 0.82
Comorbidities are frequent in patients with gastroesophageal reflux disease in a tertiary health care hospital. Clinics (Sao Paulo) (2009) 0.81
Gastrointestinal issues in the assessment and management of the obese patient. Gastroenterol Hepatol (N Y) (2007) 0.80
[Small intestinal bacterial overgrowth. An update]. Rev Med Chil (2005) 0.80
Functional dyspepsia and nonerosive reflux disease: clinical interactions and their implications. MedGenMed (2007) 0.80
A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation. Curr Med Res Opin (2012) 0.80
Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome. Psychopharmacology (Berl) (2014) 0.80
Gastrointestinal motility problems in critical care: a clinical perspective. J Dig Dis (2014) 0.79
Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Am J Gastroenterol (2009) 0.79
Emerging treatments for chronic constipation. Expert Opin Emerg Drugs (2013) 0.78
Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum (2009) 0.78
Carriage of Clostridium difficile in outpatients with irritable bowel syndrome. J Med Microbiol (2012) 0.78
Functional gastrointestinal disease: has the genomic era arrived? Gastroenterology (2004) 0.78
Current and emerging therapies for the management of functional gastrointestinal disorders. Ther Adv Chronic Dis (2011) 0.78
Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic. Gut Microbes (2013) 0.77
"Irritable bowel symptoms" in inflammatory bowel disease: diagnostic uncertainty meets pathological reality. Am J Gastroenterol (2012) 0.77
Evaluation of the quality of clinical practice guidelines for the management of esophageal or gastric variceal bleeding. Eur J Gastroenterol Hepatol (2014) 0.77
WGO--Rome foundation joint symposium summary: IBS--the global perspective. J Clin Gastroenterol (2011) 0.77
Impact of bloating and distention in irritable bowel syndrome: have we wandered too far from the Manning creed? Clin Gastroenterol Hepatol (2008) 0.77
Diet and irritable bowel syndrome. Curr Opin Gastroenterol (2015) 0.77
New perspectives on the role of the intestinal flora in health and disease. J Gastrointestin Liver Dis (2006) 0.77
Probiotics in functional bowel disorders getting it right. J Clin Gastroenterol (2011) 0.77
Autoimmune hepatitis in association with lymphocytic colitis. J Clin Gastroenterol (2006) 0.77
Interactions between symptoms and motor and visceral sensory responses of irritable bowel syndrome patients to spasmolytics (antispasmodics). J Gastrointestin Liver Dis (2009) 0.76
Open channels for functional bowel disorders: guanylate cyclase C agonists in IBS and CC. Dig Dis Sci (2013) 0.75
The microbiota and bariatric surgery: it's a bug's life. Gastroenterology (2011) 0.75
Microbial therapy in liver disease: probiotics probe the microbiome-gut-liver-brain axis. Gastroenterology (2014) 0.75
Use of evidence in WHO recommendations. Lancet (2007) 0.75
The American College of Gastroenterology irritable bowel syndrome monograph: translating systematic review data to clinical practice. Gastroenterology (2009) 0.75
Bacteria, genetics and irritable bowel syndrome. Expert Rev Gastroenterol Hepatol (2010) 0.75
Getting categorical on GERD. Am J Gastroenterol (2007) 0.75
Functional dyspepsia: eosinophils, macrophages, and the postinfectious state. Gastroenterology (2011) 0.75
Colorectal sensation and motility. Curr Opin Gastroenterol (2014) 0.75
Irritable bowel syndrome: recent progress in pathophysiology, diagnosis and management? J Ayub Med Coll Abbottabad (2010) 0.75
Colonic ischemia: usual and unusual presentations and their management. Curr Opin Gastroenterol (2016) 0.75
New WGO leadership: a glimpse into the future. J Clin Gastroenterol (2012) 0.75
Gastro-Antalya 2011: a successful regional meeting between the WGO and the TSG. J Clin Gastroenterol (2012) 0.75
James Joyce and gastroenterology. Clin Med (2008) 0.75
How the Irish savoured gastroenterology: a literary reinterpretation of the alternative history. Curr Opin Gastroenterol (2015) 0.75
Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. Clin Gastroenterol Hepatol (2012) 0.75
Bad language in gastroenterology. Curr Gastroenterol Rep (2008) 0.75